|
Volumn 431, Issue 7011, 2004, Pages 892-893
|
A shot in the arm
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTICS;
CHEMICAL INDUSTRY;
STRATEGIC PLANNING;
DRUG COMPANIES;
DISEASE CONTROL;
ANTIBIOTIC AGENT;
DAPTOMYCIN;
LINEZOLID;
LIPOPEPTIDE;
NEW DRUG;
OXAZOLIDINONE DERIVATIVE;
VANCOMYCIN;
ANTIINFECTIVE AGENT;
MEDICINE;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC RESISTANCE;
BACTERIAL INFECTION;
BACTERIAL STRAIN;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG POTENCY;
DRUG RESEARCH;
HOSPITAL INFECTION;
HUMAN;
LAW;
PATENT;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SHORT SURVEY;
TAX;
TREATMENT FAILURE;
UNITED STATES;
ANIMAL;
ARTICLE;
DRUG DESIGN;
DRUG SCREENING;
ECONOMICS;
FOOD AND DRUG ADMINISTRATION;
SYNTHESIS;
BACTERIA (MICROORGANISMS);
ANIMALS;
ANTI-BACTERIAL AGENTS;
DRUG DESIGN;
DRUG EVALUATION, PRECLINICAL;
DRUG INDUSTRY;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
PATENTS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 7244250314
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/431892a Document Type: Short Survey |
Times cited : (213)
|
References (3)
|